Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mueller Peter
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   311,837    

Indirect Shares

   25,571      
Direct Value   $69,223,526    

Indirect Value

   $12,292,747      
Total Shares   337,408      
Total Value   $81,516,273      


Vertex Pharmaceuticals Inc $68,992,927 Bioxcel Therapeutics Inc $230,598 Vertex Pharmaceuticals Inc $68,992,927 Bioxcel Therapeutics Inc $230,598
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Global R&D, CSO 2014-06-16 143,517 2014-06-16 25,571    Premium*  
            Bioxcel Therapeutics Inc BTAI Director 2019-08-23 168,320 2018-12-04 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-07-15 4 AS $86.17 $647,517 D/D (7,500) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-02-18 4 AS $82.55 $619,442 D/D (7,500) 158,750 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-07-02 4 AS $78.94 $9,758,932 D/D (122,300) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-01-15 4 AS $78.67 $590,025 D/D (7,500) 141,500 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-03-17 4 AS $78.19 $587,145 D/D (7,500) 158,750 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-08-15 4 AS $77.06 $580,560 D/D (7,500) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-09-16 4 AS $76.40 $579,160 D/D (7,500) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-10-15 4 AS $73.19 $549,365 D/D (7,500) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-06-16 4 AS $67.72 $512,352 D/D (7,500) 143,517 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-05-14 4 AS $66.13 $505,849 D/D (7,500) 143,517 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-12-12 4 AS $65.48 $189,892 D/D (2,900) 141,500 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-12-16 4 AS $64.40 $485,142 D/D (7,500) 141,500 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2013-11-15 4 AS $61.58 $469,606 D/D (7,500) 144,400 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2014-04-15 4 AS $60.57 $462,207 D/D (7,500) 158,750 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-09-17 4 AS $57.52 $373,880 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-06-15 4 AS $56.37 $366,405 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-05-16 4 AS $55.44 $142,554 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-08-15 4 AS $53.84 $351,846 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-10-15 4 AS $52.83 $344,015 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-09-20 4 AS $52.50 $1,312,500 D/D (25,000) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-07-16 4 AS $52.49 $343,060 D/D (6,500) 132,316 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2012-05-07 4 AS $52.13 $4,216,085 D/D (79,500) 148,236 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-07-15 4 AS $50.68 $126,700 D/D (2,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-09-15 4 AS $50.03 $476,848 D/D (9,500) 133,735 0 -
VRTX Vertex Pharmaceuticals In... EVP, Global R&D, CSO   •       –      –    2011-04-25 4 AS $50.00 $625,000 D/D (12,500) 133,735 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us